Cancer's Infectious Counterpart
For patients with cancer, it’s hard to believe any health condition could be scarier or deadlier than the tumor cells in their bodies. But infection—whether from compromised immune systems or cancer treatment itself—is a life-threatening safety issue many patients may face.
March 01, 2014
Healthcare safety standards
Joint Commission Toolkit Aims to Decrease Central Line-Associated Bloodstream Infections
Recent studies show that approximately 41,000 patients in the United States alone develop central line-associated bloodstream infections (CLABSIs) annually and that CLABSIs are one of the most deadly types of healthcare-associated infections.
November 25, 2013
The Case of the Double-Lumen Dilemma
Danielle has a double-lumen implanted port and is scheduled to receive rituximab for lymphoma. After accessing the lateral septum, the nurse is unable to get a blood return, even though saline flushes easily. Danielle comments that the “outside lumen hasn’t drawn well since it was placed a few months ago, and that the other nurses have been using the inside lumen.” The nurse accesses the inside lumen and is able to get a good blood return. What would you do?
July 16, 2013
ONS and ASCO Release Revised Chemotherapy Safety Standards
In 2011, a workgroup consisting of American Society of Clinical Oncology (ASCO) and ONS members was convened to review feedback received since publication of the ASCO/ONS Standards for Safe Chemotherapy Administration in 2009 and to clarify the standards as needed. The most significant change is the decision to extend their scope to the inpatient setting. This
February 27, 2012